Mira Pharmaceuticals (MIRA) Long-Term Deferred Tax (2022 - 2025)

Mira Pharmaceuticals (MIRA) has 4 years of Long-Term Deferred Tax data on file, last reported at $9.6 million in Q4 2025.

• Quarterly Long-Term Deferred Tax rose 39.13% year-over-year to $9.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.6 million (up 39.13% YoY) and the FY2025 annual result came in at $9.6 million, up 39.13% from the prior year.
• Long-Term Deferred Tax climbed to $9.6 million in Q4 2025 per MIRA's latest filing, from $6.9 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $9.6 million in Q4 2025, with the low at $1291.0 in Q4 2023.
• Average Long-Term Deferred Tax over 4 years is $4.1 million, with a median of $3.5 million recorded in 2022.
• Year-over-year, Long-Term Deferred Tax plunged 98.61% in 2023 and soared 534369.4% in 2024.
• Mira Pharmaceuticals' Long-Term Deferred Tax stood at $92736.0 in 2022, then sank by 98.61% to $1291.0 in 2023, then soared by 534369.4% to $6.9 million in 2024, then surged by 39.13% to $9.6 million in 2025.
• Business Quant data shows MIRA's Long-Term Deferred Tax at $9.6 million in Q4 2025, $6.9 million in Q4 2024, and $1291.0 in Q4 2023.